Please login to the form below

Not currently logged in
Email:
Password:

medical affairs

This page shows the latest medical affairs news and features for those working in and with pharma, biotech and healthcare.

OPEN Health expands global footprint with Pharmerit International integration

OPEN Health expands global footprint with Pharmerit International integration

in HEOR, market access, medical affairs and healthcare communications. ... We are delighted to welcome Pharmerit into the OPEN Health family – this is a key strategic integration – that will both enhance our global HEOR offering and also our global

Latest news

More from news
Approximately 1 fully matching, plus 173 partially matching documents found.

Latest Intelligence

  • The ‘blueprint’ for MSL success is changing The ‘blueprint’ for MSL success is changing

    Traditionally, the role of Medical Affairs has been to ‘assess and react,’ which evolved into ‘anticipate and inform’. ... There is no doubt that achieving Medical Affairs Excellence requires best-in-class global/regional synergies between

  • Darwinian leadership in the life sciences industry Darwinian leadership in the life sciences industry

    But pharmaceuticals and medical technology, sectors that are often integrated in their application, are exceptional in their degree of complexity on both supply and demand sides. ... across other areas, such as medical affairs, manufacturing and marketing

  • The social dilemma: is it time for pharma to join the party?

    In fact, medical congress trends are a good indicator of HCPs’ growing comfort with digital media. ... It’s an organisational shift. In the past decade, medical affairs has evolved into a proactive, customer-facing resource that’s transformed the

  • Is it time for a more integrated and human-centric approach to Medical Affairs leadership? Is it time for a more integrated and human-centric approach to Medical Affairs leadership?

    By Shairose Ebrahim. The Medical Affairs (MA) function has seen a radical transformation in recent years, evolving from a tactical team member supporting commercial activities to a strategic partner, expected to ... Yet the foundational activities of MA,

  • The trials and tribulations of rare opportunities The trials and tribulations of rare opportunities

    Preclinical trials of rare disease drugs are challenging, said Jeffrey Keefer, MD VP, Medical Strategy Head of Pediatric and Rare Disease at IQVIA. ... Jack Brownrigg, Medical Affairs, Rare Disease, Pfizer UK, told us clinical trials with fewer potential

More from intelligence
Approximately 5 fully matching, plus 39 partially matching documents found.

Latest appointments

More from appointments
Approximately 0 fully matching, plus 94 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 42 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
CSafe Global

CSafe Global is the only global provider of a full line of cold chain solutions and is the world’s largest...

Latest intelligence

OPEN Health Graduate Programme: from OPEN VIE to OPEN Health Medical Communications
Isobel Owens shares her experience of the OPEN Health Graduate Programme from OPEN VIE to OPEN Health Medical Communications...
Language barriers: Obesity has become a loaded word
...
Spotlight interview: 15 minutes on digital in medical communications
Gemma Allen, Head of Digital Communications, OPEN Health takes 15 minutes to answer some key questions on digital in medical communications...

Infographics